11
12 th Annual CTOS Meeting 2006 POST-OPERATIVE INFECTION AND INCREASED PATIENT POST-OPERATIVE INFECTION AND INCREASED PATIENT SURVIVAL IN OSTEOSARCOMA : IS THERE A LINK? SURVIVAL IN OSTEOSARCOMA : IS THERE A LINK? Lee Jeys, Rob Grimer, Simon Carter, Roger Tillman, Seggy Abudu, ROH, Birmingham, UK Several known prognostic factors for osteosarcoma Lascelles showed increased survival in dogs with post-operative infection Between 1966 & 2001 a consecutive series of 1264 patients underwent reconstruction for bone tumours Reconstructions for metastases and benign excluded Landmark analysis – Infections after 12 months excluded – Patients dying with 12 months excluded – Left 868 patients in study group

Several known prognostic factors for osteosarcoma

Embed Size (px)

DESCRIPTION

POST-OPERATIVE INFECTION AND INCREASED PATIENT SURVIVAL IN OSTEOSARCOMA : IS THERE A LINK? Lee Jeys, Rob Grimer, Simon Carter, Roger Tillman, Seggy Abudu, ROH, Birmingham, UK. Several known prognostic factors for osteosarcoma - PowerPoint PPT Presentation

Citation preview

12th Annual CTOS Meeting 2006

POST-OPERATIVE INFECTION AND INCREASED PATIENT POST-OPERATIVE INFECTION AND INCREASED PATIENT SURVIVAL IN OSTEOSARCOMA : IS THERE A LINK?SURVIVAL IN OSTEOSARCOMA : IS THERE A LINK?Lee Jeys, Rob Grimer, Simon Carter, Roger Tillman, Seggy Abudu, ROH, Birmingham, UK

• Several known prognostic factors for osteosarcoma• Lascelles showed increased survival in dogs with post-

operative infection• Between 1966 & 2001 a consecutive series of 1264

patients underwent reconstruction for bone tumours• Reconstructions for metastases and benign excluded• Landmark analysis

– Infections after 12 months excluded– Patients dying with 12 months excluded– Left 868 patients in study group

12th Annual CTOS Meeting 2006

• 89/868 patients (10.3%) endured a deep infection within 12 months of EPR implantation

• For osteosarcoma 10 year survival with no infection = 53.6% but with infection = 73.5% (p = 0.017).

• Only significant with the diagnosis of osteosarcoma• Independent prognostic factor on cox regression analysis

with other known factors with a HR=0.25• No difference in percentage necrosis between groups,

therefore, not due to more effective chemotherapy• Coley’s toxins (Streptococcus & Klebsiella) used

historically• Supporting evidence for other tumours

12th Annual CTOS Meeting 2006

12th Annual CTOS Meeting 2006

• 89/868 patients (10.3%) endured a deep infection within 12 months of EPR implantation

• For osteosarcoma 10 year survival with no infection = 53.6% but with infection = 73.5% (p = 0.017).

• Only significant with the diagnosis of osteosarcoma• Independent prognostic factor on cox regression analysis

with other known factors with a HR=0.25• No difference in percentage necrosis between groups,

therefore, not due to more effective chemotherapy• Coley’s toxins (Streptococcus & Klebsiella) used

historically• Supporting evidence for other tumours

12th Annual CTOS Meeting 2006

Determinants of Local Recurrence in Patients Undergoing Limb Sparing Surgery for Osteosarcoma of the Proximal Humerus

Patrick Lin, Giri Gupta, Valerae Lewis, Christopher Cannon, Alan Yasko, UofTexas MDACC

• Aim – Determine factors affecting local

recurrence at proximal humerus• Preservation of deltoid muscle

• Background – Routine resection of deltoid

muscle has been advocated by some authors

– Loss of deltoid could result in significant functional deficit, especially with newer forms of shoulder reconstruction

• Reverse shoulder prosthesis• Allograft-prosthetic composite

• Methods– 26 patients

• stage IIA or IIB OSA• 12 females, 14 males• Mean 19 yrs (range 7-47)

– Treatment• Pre-op: DOX + IA-CDDP x 4 • Limb-sparing surgery • Post-op chemotherapy

based upon tumor necrosis

12th Annual CTOS Meeting 2006

Local Recurrence in Osteosarcoma of the Proximal Humerus

• Results – 3/26 patients (11.5%) developed LR– 2 in sub-deltoid area

• Tumor necrosis 50% & 70%• Both patients developed Mets & LR• Both patients died

– 1 adjacent to chest wall (not sub-deltoid)– Pathologic fracture– 92% tumor necrosis– Alive 8 years after excision of LR

• Conclusions – Local recurrence may depend on several

factors, including margins, response to chemotherapy, and pathologic fracture

– Routine resection of the deltoid muscle does not appear to be warranted

12th Annual CTOS Meeting 2006

Radiation Induced Pathologic Fractures After Surgery for Soft Tissue Sarcomas

Kevan Saidi, Anthony Griffin, Peter Ferguson, Robert Bell, Jay Wunder, Mount Sinai Hospital, Toronto

Aim of Study:

• Determine healing rates of radiation induced fractures

• Determine results of surgical management

• Fracture Fixation vs Endoprosthetic Replacement

Background:

• Previous studies established risk factors for fracture

• Helmstedter (CORR 2001) - prophylactic IM nail with periosteal stripping

• Lin (CORR 1998) - Consider primary arthroplasty in proximal & distal femur

Methods:

• Retrospective review 1986 to present

• 32 patients with 34 fractures (2 acetabular fractures - 1o THA)

12th Annual CTOS Meeting 2006

Radiation Induced Pathologic Fractures After Surgery for Soft Tissue Sarcomas

Results: 11 of 34 Fractures Healed (32%)

• Femur: 25% (3/12) proximal 12% (1/8) diaphysis 50% (1/2) distal healed• Tibia: 100% (2/2) proximal 33% (1/3) diaphysis• Others: 60% (3/5) patella, metatarsals

• 5/16 (31%) healed after periosteal stripping• 4/9 (44%) Men & 7/23 (30%) Women Healed

• 2/8 (25%) healed after 50 Gy• 9/24 (38%) healed after 66 Gy

• Risk Factors For Fracture (Holt, JBJS 2005): • Females > 50, High Dose Radiation (60 or 66 Gy), Proximal 2/3 Femur

Conclusion:• Fractures of the proximal 2/3 of the femur and the tibia diaphysis are at

high risk of non-union• Primary endoprosthetic replacement should be considered when treating

pathologic radiation induced fractures of the proximal femur

4.5 yrsOR x 25 yrs

12th Annual CTOS Meeting 2006

EXTRACORPOREALLY IRRADIATED AUTOGRAFTS IN LIMB SALVAGE SURGERY

How it can solve difficult reconstruction problems

Hazem Wafa, MD; Robert Grimer, FRCS; Simon Carter, FRCS; Roger Tillman, FRCS; Adesgun Abudu; FRCS (orth)

The Royal Orthopaedic Hospital, Birmingham, UK

12th Annual CTOS Meeting 2006

Aim of the study:

To evaluate the oncological and functional outcome of extracorporeally irradiated autografts as a reconstructive technique in limb salvage surgery.

Material:• 28 patients (17 females, 11 males).• Median age 16 years (range 7-66).• 11 Ewing’s sarcoma, 8 osteogenic sarcoma, 4 parosteal osteosarcoma,

3 chondrosarcoma, 1 angiosarcoma, and 1 adamantinoma. • 14 pelvis, 6 tibia, 3 humerus, 2 scapula, 1 femur, 1 ulna, 1 metacarpal

Methods:• Wide en-bloc resection of the lesion.• Removal of soft tissues and tumor off the excised bone segment.• Wrap in two layers with Vancomycin and pack in a sealed box.• Extracorporeal irradiation with 90 Gy (35 minutes).• Reimplantation of the irradiated autograft.• Primary hip replacement was used in 7 cases, pedicled vascularized fibular

graft in 4, PMMA in 2, and non-vascularized fibula in 1.

12th Annual CTOS Meeting 2006

Results:• The average follow-up 33.9 months.• 19 patients were alive (67.9%), 17 NED and 2 AWD. • Local recurrence in 3 cases (10.7%), all occurred in the soft tissues.• The average time to union was 7.7 months. • Deep infection developed in 2 cases (7.1%) necessitating graft removal.• Fracture of the graft occurred in 2 cases, graft resorption in 2, and

non-union at 2 sites. • The mean MSTS functional score was 25.5 / 35

Conclusions:• Extracorporeal irradiation and re-implantation of bone is an excellent

technique which can solve difficult reconstruction problems in appropriately selected patients.

• This technique does not carry an increased risk of local recurrence and the overall results are comparable to other reconstructive techniques.